Theranos is considered one of the most serious corporate scandals affecting early stage startups in recent memory. Not only was $700M in investor capital incinerated, but thousands of patients risked serious health complications due to the company’s behavior. And the CEO, convicted last quarter of four counts of financial fraud, awaits sentencing. This webinar examines the role of the Board in the Theranos disaster. What did the Board do right? What did they do wrong? What are the responsibilities of the Board in regulated industries? And what could the Board have done to mitigate risks or turn the situation around? Ron Weissman, the ACA Vice Chair and author of Angel University’s course on Boards of Directors will review Theranos from the perspective of its Board and draw lessons applicable to any early stage Board of Directors.
Speaker: Ron Weissman, Band of Angels